FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35598311000001103: Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jul 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
107575101000001110 Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
107575201000001115 Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has VMP Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
MagnaPhos 39.5mg (1.6mmol) capsules (TriOn Pharma Ltd) 50 capsule Is a True Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Inferred relationship Existential restriction modifier
MagnEss Gly 39.5mg (1.6mmol) capsules (Essential-Healthcare Ltd) 50 capsule Is a True Magnesium glycerophosphate (magnesium 39.5mg (1.6mmol)) capsules 50 capsule Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start